Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer

The aim of the present study was to observe the efficacy of neoadjuvant trastuzumab combined with docetaxel and carboplatin (TCH), and docetaxel, epirubicin and cyclophosphamide (TEC) chemotherapy in human epidermal growth factor receptor-2 (HER-2)-overexpressing breast cancer. The total cohort of 6...

Descripción completa

Detalles Bibliográficos
Autores principales: CHEN, WEICAI, HE, JINSONG, SONG, SHUFEN, WANG, MIN, WU, HUISHENG, WANG, XIANMING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356353/
https://www.ncbi.nlm.nih.gov/pubmed/25789069
http://dx.doi.org/10.3892/ol.2015.2912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356353/
https://www.ncbi.nlm.nih.gov/pubmed/25789069
http://dx.doi.org/10.3892/ol.2015.2912

Ejemplares similares